We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATVI
226
DELISTED
Activision Blizzard
ATVI
| $15.8M | 0.07% |
184,483
+8,451
| +5% | +$656K |
|
227
Oneok
OKE
$58.3B
| $15.7M | 0.07% |
247,646
-352,037
| -59% | -$23.4M |
|
|
SGEN
228
DELISTED
Seagen Inc. Common Stock
SGEN
| $15.5M | 0.07% |
76,484
+35,875
| +88% | +$5.75M |
|
229
Regency Centers
REG
$13.9B
| $15.4M | 0.07% |
251,270
+763
| +0.3% | +$48K |
|
230
Trane Technologies
TT
$105B
| $15.3M | 0.07% |
82,959
+4,375
| +6% | +$794K |
|
231
Datadog
DDOG
$86.5B
| $15.3M | 0.07% |
210,000
-207,219
| -50% | -$15.2M |
|
232
Humana
HUM
$46.7B
| $14.7M | 0.07% |
30,231
-44,464
| -60% | -$22M |
|
233
Pegasystems
PEGA
$5.15B
| $14.7M | 0.07% |
+605,330
| New | +$12.8M |
|
234
Tradeweb Markets
TW
$21.9B
| $14.6M | 0.07% |
185,210
+121,409
| +190% | +$8.79M |
|
235
Labcorp
LH
$26.2B
| $14.5M | 0.06% |
73,748
-6,152
| -8% | -$1.27M |
|
|
PINC
236
DELISTED
Premier
PINC
| $14.4M | 0.06% |
446,329
-59,920
| -12% | -$1.96M |
|
237
Union Pacific
UNP
$174B
| $14.2M | 0.06% |
70,671
+41,656
| +144% | +$8.44M |
|
238
Halliburton
HAL
$27.7B
| $14.2M | 0.06% |
448,813
+107,617
| +32% | +$3.99M |
|
239
Aon
AON
$74.7B
| $13.9M | 0.06% |
+44,162
| New | +$13.7M |
|
240
Synopsys
SNPS
$79B
| $13.9M | 0.06% |
35,983
+5,752
| +19% | +$2.06M |
|
241
Liberty Global Class C
LBTYK
$3.46B
| $13.8M | 0.06% |
678,244
+655,138
| +2,835% | +$13.8M |
|
242
Estee Lauder
EL
$31.7B
| $13.6M | 0.06% |
55,158
-5,220
| -9% | -$1.33M |
|
243
MGM Resorts International
MGM
$11.1B
| $13.5M | 0.06% |
304,353
+161,705
| +113% | +$6.72M |
|
244
Domino's
DPZ
$11.7B
| $13.1M | 0.06% |
+39,795
| New | +$13.2M |
|
245
Jabil
JBL
$38.4B
| $12.8M | 0.06% |
145,401
-548,625
| -79% | -$44.2M |
|
246
Aecom
ACM
$7.85B
| $12.8M | 0.06% |
151,327
+52,809
| +54% | +$4.55M |
|
247
Vipshop
VIPS
$6.94B
| $12.5M | 0.06% |
821,819
+602,254
| +274% | +$8.95M |
|
248
Interactive Brokers
IBKR
$41.5B
| $12.4M | 0.05% |
598,560
-603,428
| -50% | -$12.3M |
|
249
Mondelez International
MDLZ
$79.4B
| $12.3M | 0.05% |
176,600
+82,061
| +87% | +$5.44M |
|
250
Idexx Laboratories
IDXX
$45B
| $12.2M | 0.05% |
24,486
-510
| -2% | -$244K |
|
Similar funds
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.